Skip to main content
Advertisement
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
      • Doodle Gallery
      • Circulation Cover Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
      • Hospital Santa Maria del Popolo, Naples, Italy
      • Minneapolis City Hospital
      • Pitié-Salpêtrière Hospital
      • Tufts Medical Center
      • Uppsala University Hospital
      • Vassar Brothers Medical Center (Poughkeepsie, NY)
      • Wroclaw Medical University
    • On My Mind
    • Podcast Archive
      • → Circulation on the Run, FIT Edition
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Circulation Doodle
    • → Blip the Doodle
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Bridging Disciplines
    • → Articles Bridging Discplines
    • Cardiovascular Case Series
    • Circulation Supplements
    • ECG Challenge
    • Hospitals of History
    • On My Mind
    • Podcast Archive
    • → Subscribe to Circulation on the Run
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • Circulation CME
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
    • Scientific Sessions 2017
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

Search for author "Zhaohua Cai"

  • Modify Search
  • Create Alert
  • Save Search

8 Results

Type a term to search within all articles in this journal: e.g., stem cell
Content Type
Select types of content to include in the results.
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
e.g., 08/02/2017
e.g., 08/02/2017
Format Results
  • You have accessRestricted access
    Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
    Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro and Gregg L. Semenza
    Circulation Research. 2003;93:1074-1081, originally published November 26, 2003
    https://doi.org/10.1161/01.RES.0000102937.50486.1B
    Download PDF
  • You have access
    Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
    Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro, Gregg L. Semenza
    Circulation Research November 2003, 93 (11) 1074-1081; DOI: https://doi.org/10.1161/01.RES.0000102937.50486.1B
    By Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro and Gregg L. Semenza
    Figure 1. Analysis of angiogenic factor gene expression in cultured cells. Primary cultures of cardiac myocytes (A), cardiac fibroblasts (B), arterial...Show More
    Figure 1. Analysis of angiogenic factor gene expression in cultured cells. Primary cultures of cardiac myocytes (A), cardiac fibroblasts (B), arterial endothelial cells (C), or arterial SMCs (D) were incubated for 24 hours under nonhypoxic (20% O2) or hypoxic (1% O2) conditions or under nonhypoxic conditions in the presence of AdLacZ or AdCA5 at a multiplicity of infection of 25 pfu/cell. Total RNA was analyzed by RT-PCR. E, Structure of HIF-1α and CA5. The basic helix-loop-helix (bHLH) and PAS domains of HIF-1α that are required for dimerization with HIF-1β and DNA binding are intact in CA5, as are the amino- and carboxyl-terminal transactivation domains (TAD-N and TAD-C, respectively). However, O2-dependent degradation of HIF-1α under nonhypoxic conditions is impaired by deletion of amino acids 392 through 520 and the missense mutations Pro567Thr (P567Q) and Pro658Gln (P658Q). F, Summary of changes in gene expression induced by hypoxia or AdCA5. Exposure of cardiac myocytes (CM), cardiac fibroblasts (CF), arterial ECs (EC), and arterial SMCs (SM) to 1% O2 or AdCA5 infection either increased (green), decreased (red), or had no effect (yellow) on the expression of the indicated angiogenic growth factor mRNAs relative to the appropriate control (20% O2 and AdLacZ infection, respectively). G, Gene expression in ES cells. Real-time RT-PCR was performed to analyze total RNA isolated from Hif1a+/+ and Hif1a−/− ES cells that were incubated under nonhypoxic (20% O2) or hypoxic (1% O2) conditions for 24 hours. The mean (n=3) fold induction in hypoxic cells is shown for each mRNA.Show Less
  • You have access
    Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
    Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro, Gregg L. Semenza
    Circulation Research November 2003, 93 (11) 1074-1081; DOI: https://doi.org/10.1161/01.RES.0000102937.50486.1B
    By Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro and Gregg L. Semenza
    Figure 2. Histochemical analysis of retinal vasculature after subretinal injection. Tissue was harvested 3 days after subretinal injection of AdCA5 (l...Show More
    Figure 2. Histochemical analysis of retinal vasculature after subretinal injection. Tissue was harvested 3 days after subretinal injection of AdCA5 (left) and AdLacZ (right). Sections were stained with GSA or anti–α-smooth muscle actin antibodies (SMA) to detect vascular endothelial and pericytes/SMCs, respectively. Increased staining in AdCA5-treated eyes was detected in the INL (large arrows) and at the site of injection (small arrows). Retinal layers: GC indicates ganglion cells; INL, inner nuclear layer; ONL, outer nuclear layer; and RPE, retinal pigment epithelium.Show Less
  • You have access
    Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
    Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro, Gregg L. Semenza
    Circulation Research November 2003, 93 (11) 1074-1081; DOI: https://doi.org/10.1161/01.RES.0000102937.50486.1B
    By Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro and Gregg L. Semenza
    Figure 3. Immunohistochemical analyses of HIF-1α and PLGF expression. Tissue was harvested from AdCA5- and AdLacZ-injected eyes 24 hours or 6 days aft...Show More
    Figure 3. Immunohistochemical analyses of HIF-1α and PLGF expression. Tissue was harvested from AdCA5- and AdLacZ-injected eyes 24 hours or 6 days after subretinal injection, and sections were stained with antibodies against HIF-1α or PLGF, respectively. HIF-1α expression is observed at the site of AdCA5 injection (arrows). In AdCA5-injected eyes, PLGF expression is prominent in the INL (vertical arrows) with vertical lines in the inner plexiform layer (horizontal arrows) typical of Muller cell processes and irregular horizontal linear-stained structures near the surface of the retina (arrowheads) typical of Muller cell end feet. In AdLacZ-injected eyes, modest PLGF staining is observed in the INL and near the retinal surface.Show Less
  • You have access
    Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
    Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro, Gregg L. Semenza
    Circulation Research November 2003, 93 (11) 1074-1081; DOI: https://doi.org/10.1161/01.RES.0000102937.50486.1B
    By Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro and Gregg L. Semenza
    Figure 4. Analysis of gene expression after subretinal injection of AdCA5. RNA was isolated from the retinas of eyes 24 hours after injection with AdC...Show More
    Figure 4. Analysis of gene expression after subretinal injection of AdCA5. RNA was isolated from the retinas of eyes 24 hours after injection with AdCA5 and AdLacZ. Expression of mRNA encoding HIF-1α and the indicated angiogenic growth factors was analyzed by real-time RT-PCR. For each mRNA, the fold induction in the AdCA5-treated eye relative to the AdLacZ-treated eye of each mouse was determined as described in Materials and Methods. Mean and SE (n=3) are shown.Show Less
  • You have access
    Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
    Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro, Gregg L. Semenza
    Circulation Research November 2003, 93 (11) 1074-1081; DOI: https://doi.org/10.1161/01.RES.0000102937.50486.1B
    By Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro and Gregg L. Semenza
    Figure 5. Histochemical analysis of retinal vasculature after intravitreous injection. Sections from the indicated regions of mouse eyes that received...Show More
    Figure 5. Histochemical analysis of retinal vasculature after intravitreous injection. Sections from the indicated regions of mouse eyes that received an intravitreous injection of AdCA5 or AdLacZ 6 days earlier were stained with GSA lectin or anti-SMA antibodies. Left (red box), In sections from AdCA5-injected eyes, retinal neovascular tufts (arrows) were seen projecting above the inner limiting membrane (ILM; demarcated by arrowheads). Right (green box), Corneal neovascularization that stained positively for GSA and SMA (arrows) was observed in AdCA5-injected eyes but not in AdLacZ-injected eyes. There was also staining for GSA and SMA in the iridocorneal angle (arrowheads).Show Less
  • You have access
    Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
    Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro, Gregg L. Semenza
    Circulation Research November 2003, 93 (11) 1074-1081; DOI: https://doi.org/10.1161/01.RES.0000102937.50486.1B
    By Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro and Gregg L. Semenza
    Figure 6. Gene expression after intravitreous adenoviral injection. Total RNA was isolated from whole eyes at the indicated time after intravitreous i...Show More
    Figure 6. Gene expression after intravitreous adenoviral injection. Total RNA was isolated from whole eyes at the indicated time after intravitreous injection of AdCA5 and AdLacZ. The fold induction of HIF-1α, PLGF, VEGF, ANGPT1, ANGPT2, and PDGFB mRNA in the AdCA5-injected eye relative to the AdLacZ-injected eye of each mouse was determined by real-time RT-PCR. Mean and SE (n=3 to 5) are shown.Show Less
  • You have access
    Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1
    Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro, Gregg L. Semenza
    Circulation Research November 2003, 93 (11) 1074-1081; DOI: https://doi.org/10.1161/01.RES.0000102937.50486.1B
    By Brian D. Kelly, Sean F. Hackett, Kiichi Hirota, Yuji Oshima, Zheqing Cai, Shannon Berg-Dixon, Ashley Rowan, Zhijiang Yan, Peter A. Campochiaro and Gregg L. Semenza
    Figure 7. Regulation of angiogenesis by HIF-1. In a cell type–specific manner, HIF-1 can either activate (arrow) or repress (blocked arrow) expression...Show More
    Figure 7. Regulation of angiogenesis by HIF-1. In a cell type–specific manner, HIF-1 can either activate (arrow) or repress (blocked arrow) expression of genes encoding angiogenic growth factors (PLGF, VEGF, ANGPT1, ANGPT2, and PDGFB) that bind to receptors (VEGFR1, VEGFR2, TIE2, and PDGFR) on vascular ECs or SMCs. Receptor signaling leads to critical events required for physiological angiogenesis.Show Less
Back to top

Selected Facets

Selected Facets

  • Physiological and pathological control of gene expression (Article Type)

Subject

Subject

  • Angiogenesis 8
  • Gene therapy 8
  • Physiological and pathological control of gene expression 8

Content Type

Resource Type

  • Articles 1
  • Tables & Figures 7
Advertisement
Advertisement

Circulation

  • About Circulation
  • Instructions for Authors
  • Circulation CME
  • Statements and Guidelines
  • Meeting Abstracts
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451
email: circ@circulationjournal.org
 

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured